Skip to main menu Skip to main content Skip to footer
neurotech logo Accessibility Menu
Healthcare Professionals
  • About Us
    • Our Team
      • Leadership Team
      • Medical Advisory Board
    • Careers
    • Contact Us
  • Our Product
  • Science & Technology
    • Publications
  • Clinical
  • Patients
  • News
  • Healthcare Professionals

Category: Featured

Home » Featured » Page 3

Media Contact

Monique Watson
m.smith@neurotechusa.com

Click to read NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

July 24, 2012

NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

< 1 2 3
neurotech logo
About Us Science & Technology Clinical Patients Our Product News Careers Publications
Stay Connected
Linked
,
Twitter
,
Instagram
Contact Us
Main Phone Number
Phone Icon 401-333-3880
Headquarters
Map Pin Icon
900 Highland Corporate Drive,
Suite 101
Cumberland, RI 02864
Commercial Office
Map Pin Icon
75 Second Ave, Suite 700
Needham, MA 02494
Accessibility Statement | Compliance | Privacy Policy | Consumer Health Data Privacy Notice | Supplier Code of Conduct Policy | Terms and Conditions of Use Policy
© Neurotech Pharmaceuticals, Inc. 2026
Designed by Glacial Multimedia.
⇧
Neurotech Pharmaceuticals, Inc. is now part of Alcon